In an era where precision medicine and rapid drug development are paramount, the clinical trials support software solutions ...

Software stocks might not be a very popular way to play the artificial-intelligence trade today, but that could soon change. Back To Top ...

RUNNING A GIANT software business used to be fun. Sure, coming up with a great product was a grind. But once you had one that customers could not live without—be it Microsoft Office, Amazon.com, ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — The Food and Drug ...

Oracle is aggressively building out AI data centers, most notably for OpenAI under a massive multi-year deal The company's balance sheet is already loaded with debt, and more debt is being piled on to ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...

Thermo Fisher Scientific, already a big player in providing services to the biopharmaceutical industry, is adding to its technology capabilities with the $9 billion acquisition of clinical trial ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The largest medical device maker ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The largest medical device maker ...

Oracle Health and Life Sciences Executive Vice President and General Manager Seema Verma said Tuesday that artificial intelligence may be the key to closing the gap between administering quality ...